Your browser doesn't support javascript.
loading
Functional heterogeneity of POMC neurons relies on mTORC1 signaling.
Saucisse, Nicolas; Mazier, Wilfrid; Simon, Vincent; Binder, Elke; Catania, Caterina; Bellocchio, Luigi; Romanov, Roman A; Léon, Stéphane; Matias, Isabelle; Zizzari, Philippe; Quarta, Carmelo; Cannich, Astrid; Meece, Kana; Gonzales, Delphine; Clark, Samantha; Becker, Julia M; Yeo, Giles S H; Fioramonti, Xavier; Merkle, Florian T; Wardlaw, Sharon L; Harkany, Tibor; Massa, Federico; Marsicano, Giovanni; Cota, Daniela.
Affiliation
  • Saucisse N; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Mazier W; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Simon V; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Binder E; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Catania C; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Bellocchio L; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Romanov RA; Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria.
  • Léon S; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Matias I; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Zizzari P; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Quarta C; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Cannich A; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Meece K; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
  • Gonzales D; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Clark S; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Becker JM; Medical Research Council (MRC) Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Yeo GSH; Medical Research Council (MRC) Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
  • Fioramonti X; NutriNeuro, UMR 1286 INRAE, Bordeaux University, Bordeaux INP, F-33000 Bordeaux, France.
  • Merkle FT; Medical Research Council (MRC) Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK; Wellcome Trust-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Puddicombe
  • Wardlaw SL; Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
  • Harkany T; Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria; Department of Neuroscience, Karolinska Institutet, SE-17177 Stockholm, Sweden.
  • Massa F; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Marsicano G; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France.
  • Cota D; University of Bordeaux, INSERM, Neurocentre Magendie, U1215, F-3300 Bordeaux, France. Electronic address: daniela.cota@inserm.fr.
Cell Rep ; 37(2): 109800, 2021 10 12.
Article in En | MEDLINE | ID: mdl-34644574
Hypothalamic pro-opiomelanocortin (POMC) neurons are known to trigger satiety. However, these neuronal cells encompass heterogeneous subpopulations that release γ-aminobutyric acid (GABA), glutamate, or both neurotransmitters, whose functions are poorly defined. Using conditional mutagenesis and chemogenetics, we show that blockade of the energy sensor mechanistic target of rapamycin complex 1 (mTORC1) in POMC neurons causes hyperphagia by mimicking a cellular negative energy state. This is associated with decreased POMC-derived anorexigenic α-melanocyte-stimulating hormone and recruitment of POMC/GABAergic neurotransmission, which is restrained by cannabinoid type 1 receptor signaling. Electrophysiology and optogenetic studies further reveal that pharmacological blockade of mTORC1 simultaneously activates POMC/GABAergic neurons and inhibits POMC/glutamatergic ones, implying that the functional specificity of these subpopulations relies on mTORC1 activity. Finally, POMC neurons with different neurotransmitter profiles possess specific molecular signatures and spatial distribution. Altogether, these findings suggest that mTORC1 orchestrates the activity of distinct POMC neurons subpopulations to regulate feeding behavior.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraventricular Hypothalamic Nucleus / Appetite Regulation / Pro-Opiomelanocortin / Glutamic Acid / Feeding Behavior / GABAergic Neurons / Mechanistic Target of Rapamycin Complex 1 / Neural Inhibition Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Rep Year: 2021 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraventricular Hypothalamic Nucleus / Appetite Regulation / Pro-Opiomelanocortin / Glutamic Acid / Feeding Behavior / GABAergic Neurons / Mechanistic Target of Rapamycin Complex 1 / Neural Inhibition Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Rep Year: 2021 Document type: Article Affiliation country: France Country of publication: United States